Clinical Insights from the SMART 2y and Low Risk 5y TAVR Trials
Description
Join hosts Dr. Dan O'Hair and Dr. Suzanne Baron in this compelling episode as they engage with esteemed guests Dr. Howard Herrmann and Dr. Michael Reardon, principal investigators of the SMART and Evolut Low Risk trials, respectively.
Together, they explore the evolving landscape of structural heart interventions, analyzing groundbreaking data, clinical implications, and the future of patient care. From trial design to real-world applications, Dr. Herrmann and Dr. Reardon share firsthand insights into the science shaping tomorrow’s standards in cardiology.
Whether you're a clinician, researcher, or simply passionate about cardiovascular innovation, this episode delivers invaluable perspectives straight from the frontlines of clinical discovery.
United States
